Exploring the optimal follow-up time for resectable colorectal cancer patients: a multicenter, five-year longitudinal cohort study

Why the timing of checkups matters

For people who have had surgery to remove colorectal cancer, life after the operating room is filled with questions. How often do they really need to go back for scans and blood tests? Can a smarter schedule catch trouble early without piling on needless costs and stress? This study followed nearly six thousand patients across several major hospitals in China to pinpoint when follow-up visits are most useful for predicting who will do well in the long run. By turning routine test results into a living, continuously updated picture of risk, the researchers show that timing those visits right could save lives and money.

A new way to track recovery

Instead of looking at patients only once, this research tracked them repeatedly for up to 14 years after surgery. The team gathered a wide range of information: age, weight, tumor stage, surgical details, chemotherapy, and microscopic tumor features, along with blood tests taken many times during follow-up. They then built a system called CCC-DISPO that combines these pieces into a single dynamic picture of each patient’s chances of survival. Unlike traditional one-time calculators, this model is designed to evolve as new test results come in, more like a weather forecast that updates with every new satellite image.

How the model judges risk over time

The heart of this work is a statistical engine that links two stories: how a person’s lab results change over months and years, and whether and when that person dies from cancer. By tying those stories together, CCC-DISPO can estimate the risk of death at different future time points each time new follow-up data arrive. The researchers tested how well the system performed using several standard measures of accuracy, both in the original hospital where it was built and in two independent hospitals. In these outside settings, the model still performed strongly, suggesting it can generalize beyond a single clinic.

Finding the most valuable checkup windows

Because the model’s accuracy rises and falls at different follow-up times, the team treated its performance as a guide to when checkups are most informative. For all patients combined, the model worked best around six months after surgery and stayed reliable for the first three years. When they looked at cancer stages separately, they found important differences. For early cancers (stage I), results from checkups within the first year—especially at three and six months—were highly informative, after which the benefit of frequent testing dropped. For intermediate stages (II and III), model performance was consistently good when follow-up began around three months and continued regularly. In the most advanced stage (IV), very early visits in the first month added little clarity, but later visits from three months onward remained helpful.

What this means for patients and clinics

These findings suggest that many very early visits—those before three months after surgery—may add little to understanding a patient’s long-term outlook, while checkups around three to six months carry much more weight. For stage I patients, more frequent visits in the first year, then fewer later on, may provide the right balance between vigilance and burden. For stages II to IV, the study supports beginning serious follow-up at three months and keeping it steady for at least three years. Rather than replacing existing guidelines, the authors see their model as a first step toward tailoring follow-up to each person’s actual risk, potentially freeing resources where they matter most.

Looking ahead to smarter, leaner care

To a layperson, the takeaway is straightforward: it is not just how many checkups you have after colorectal cancer surgery, but when you have them that counts. By using ordinary lab tests gathered over time, the CCC-DISPO system can highlight critical windows—especially around the three- and six-month marks—when follow-up carries the greatest power to predict the future. While this model still needs to be tested in everyday clinical practice and in more countries, it points toward a future where follow-up schedules are shaped by data instead of habit, helping patients stay safe without unnecessary visits and costs.

Citation: Kang, B., Qiao, Y., Wang, Y. et al. Exploring the optimal follow-up time for resectable colorectal cancer patients: a multicenter, five-year longitudinal cohort study. Sci Rep 16, 8888 (2026). https://doi.org/10.1038/s41598-026-41611-2

Keywords: colorectal cancer, postoperative follow-up, survival prediction, longitudinal data, risk modeling